US 12,465,686 B2
Emergency medicament dose control
Michael J. Rosinko, Las Vegas, NV (US); Firas H. El-Khatib, Allston, MA (US); Edward R. Damiano, Acton, MA (US); David Chi-Wai Lim, Irvine, CA (US); and Edward B. Raskin, Irvine, CA (US)
Assigned to Beta Bionics, Inc., Concord, MA (US)
Filed by Beta Bionics, Inc., Concord, MA (US)
Filed on Aug. 5, 2022, as Appl. No. 17/882,469.
Application 17/882,469 is a continuation of application No. PCT/US2022/071308, filed on Mar. 24, 2022.
Application PCT/US2022/071308 is a continuation in part of application No. PCT/US2022/017368, filed on Feb. 22, 2022.
Application PCT/US2022/017368 is a continuation in part of application No. PCT/US2021/064228, filed on Dec. 17, 2021.
Application PCT/US2022/017368 is a continuation in part of application No. PCT/US2021/072742, filed on Dec. 3, 2021.
Application PCT/US2022/017368 is a continuation in part of application No. 17/212,984, filed on Mar. 25, 2021, granted, now 11,957,876.
Claims priority of provisional application 63/321,514, filed on Mar. 18, 2022.
Claims priority of provisional application 63/320,591, filed on Mar. 16, 2022.
Claims priority of provisional application 63/320,587, filed on Mar. 16, 2022.
Claims priority of provisional application 63/295,361, filed on Dec. 30, 2021.
Claims priority of provisional application 63/264,645, filed on Nov. 29, 2021.
Claims priority of provisional application 63/263,602, filed on Nov. 5, 2021.
Claims priority of provisional application 63/276,481, filed on Nov. 5, 2021.
Claims priority of provisional application 63/249,975, filed on Sep. 29, 2021.
Claims priority of provisional application 63/261,290, filed on Sep. 16, 2021.
Claims priority of provisional application 63/239,365, filed on Aug. 31, 2021.
Claims priority of provisional application 63/238,670, filed on Aug. 30, 2021.
Claims priority of provisional application 63/216,177, filed on Jun. 29, 2021.
Claims priority of provisional application 63/215,857, filed on Jun. 28, 2021.
Claims priority of provisional application 63/212,521, filed on Jun. 18, 2021.
Claims priority of provisional application 63/194,126, filed on May 27, 2021.
Claims priority of provisional application 63/183,900, filed on May 4, 2021.
Claims priority of provisional application 63/169,112, filed on Mar. 31, 2021.
Claims priority of provisional application 63/168,203, filed on Mar. 30, 2021.
Claims priority of provisional application 63/167,563, filed on Mar. 29, 2021.
Prior Publication US 2023/0166035 A1, Jun. 1, 2023
Int. Cl. A61M 5/172 (2006.01); A61B 5/145 (2006.01); G16H 20/17 (2018.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); G16H 20/17 (2018.01)] 15 Claims
OG exemplary drawing
 
1. A glucose level control system configured to modify a manual therapy instruction and to generate an emergency dose control signal for commanding administration of modified glucose control therapy to a subject via a medicament pump, the glucose level control system comprising:
a data interface configured to receive a glucose level of the subject;
a non-transitory memory configured to store specific computer-executable instructions; and
an electronic processor in communication with the non-transitory memory and configured to execute the specific computer-executable instructions to at least:
receive, via a manual therapy control interface, the manual therapy instruction;
based on the manual therapy instruction, transmit an initial dose control signal to a pump controller of the medicament pump;
receive, via the data interface, the glucose level of the subject; determine, based at least in part on the glucose level, that the initial dose
control signal does not indicate health-appropriate therapy;
based on the determination that the initial dose control signal does not indicate health-appropriate therapy, generate the emergency dose control signal for commanding administration of modified glucose control therapy to the subject via the medicament pump; and
based on the emergency dose control signal, modify the manual therapy instruction and transmit, via the data interface, the emergency dose control signal to the pump controller of the medicament pump along with graphic user interface updating and concomitant visual displays.